Clinical trial
A Multicenter, Randomized, Open Label Study to Compare the Efficacy of Cinacalcet Versus Traditional Vitamin D Therapy for Management of Secondary Hyperparathyroidism Among Subjects Undergoing Hemodialysis
NCT01181531 is registered in ClinicalTrials.gov with Amgen as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Multicenter, Randomized, Open Label Study to Compare the Efficacy of Cinacalcet Versus Traditional Vitamin D Therapy for Management of Secondary Hyperparathyroidism Among Subjects Undergoing Hemodialysis
- Lead sponsor
- Amgen
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- October 1, 2010
- Completion date
- August 14, 2012
- Enrollment
- 312 (actual)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.